{
  "id": 13569172,
  "title": "Ul solutions CEO Jennifer Scanlon sells $876,035 in company stock",
  "url": "https://urgent.news/2026/10/10/ul-solutions-ceo-jennifer-scanlon-sells-876-035-in-company-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-10T23:00:59.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/ul-solutions-ceo-jennifer-scanlon-sells-876035-in-company-stock-93CH-4942298"
  },
  "original_language": "en",
  "account": "On October 8, 2026, Jennifer F. Scanlon, the President and CEO of UL Solutions Inc. (ULS), sold 12,500 shares of Class A Common Stock, amounting to $876,035. The sale took place amidst a decline in ULS stock price, which is currently trading at $69.99, marking an 11% decrease year-to-date and a 35% drop below its 52-week high of $107.54. Despite the recent price weakness, InvestingPro analysis suggests that the stock remains undervalued compared to its Fair Value, earning a spot on the platform's list of undervalued stocks. Ms. Scanlon sold these shares at a weighted average price of $70.0828 per share, within a range of $70.00 to $70.15. The transactions were executed under a pre-established Rule 10b5-1 trading plan, adopted by Ms. Scanlon on December 9, 2025.\n\nThe sale resulted in Ms. Scanlon's direct ownership of 126,724 shares of UL Solutions Class A Common Stock. Furthermore, she indirectly owns 89,285 shares through her family trust, with her spouse as trustee and her children as beneficiaries. ULS is among over 1,400 US equities covered by InvestingPro's Pro Research Reports.\n\nEarlier this month, UL Solutions reported its second-quarter 2026 financial results, which beat Wall Street's earnings expectations. Adjusted earnings per share were $0.59, surpassing the forecasted $0.51, while revenue increased to $816 million. Organic growth was reported at 6.6%, and adjusted EBITDA reached a record $219 million, with a margin expansion to 26.8%. However, investors expressed concerns about future spending and margin outlooks. In response, William Blair maintained an Outperform rating on UL Solutions, following discussions with key company executives during investor meetings. The conversations centered on growth dynamics, demand drivers such as AI and electrification, and potential mergers and acquisitions. This report highlights UL Solutions' robust fundamentals and strategic focus areas.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Rapport Therapeutics CEO Abraham Ceesay sells $143,272 in stock",
        "url": "https://urgent.news/2026/10/10/rapport-therapeutics-ceo-abraham-ceesay-sells-143-272-in-stock",
        "published": "2026-10-10T17:31:06.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}